Literature DB >> 6293976

The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.

A von Graevenitz, C Bucher.   

Abstract

Thirty-one species (185 strains) of non-fermentative gram-negative rods (excluding Pseudomonas aeruginosa) as well as 45 strains of Aeromonas spp., 15 strains of Plesiomonas shigelloides and 68 strains of Enterobacter agglomerans were tested in microdilution procedures against N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime. N-formimidoyl thienamycin was the most effective drug as far as the spectrum of these bacterial groups and potency is concerned; ceftazidime was the second most effective agent. Ceftriaxone and cefotaxime were similar in their activity (against a smaller spectrum), while cefotiam showed little effect. There were occasional differences between MBC and MIC values which were most notable with ceftazidime, cefotiam, ceftriaxone and cefotaxime against E. agglomerans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6293976     DOI: 10.1007/bf01640878

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

1.  The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin.

Authors:  A King; C Warren; K Shannon; I Phillips
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

2.  In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Antimicrob Chemother       Date:  1980-11       Impact factor: 5.790

3.  Antimicrobial susceptibility of Acinetobacter calcoaceticus, Serratia marcescens, Pseudomonas fluorescens and Pseudomonas maltophilia to three novel cephalosporin-like antibiotics.

Authors:  R W Tofte; K Crossley
Journal:  J Antimicrob Chemother       Date:  1980-11       Impact factor: 5.790

Review 4.  Erwinia infections in man.

Authors:  S S Schneierson; E J Bottone
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1973-12

5.  In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their beta-lactamases.

Authors:  D M Livermore; R J Williams; J D Williams
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

6.  The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.

Authors:  M Stephens; M Potten; A J Bint
Journal:  Infection       Date:  1979       Impact factor: 3.553

7.  Activity of ceftazidime and newer antibiotics against Gram-negative bacilli.

Authors:  H H Schassan; J Fedder
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790

8.  Activity of ceftazidime against Pseudomonas aeruginosa from bacteraemic and fibrocystic patients.

Authors:  P C Fleming; B Knie
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790

9.  Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.

Authors:  R N Jones; A L Barry; C Thornsberry; E H Gerlach; P C Fuchs; T L Gavan; H M Sommers
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790

10.  Activity of ceftazidime (GR 20263) against nosocomially important pathogens.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

View more
  13 in total

1.  Antimicrobial susceptibility of Plesiomonas shigelloides from patients with diarrhea.

Authors:  K C Kain; M T Kelly
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Resignment: Infection is grateful to Prof. Alexander von Graevenitz.

Authors:  Johannes R Bogner
Journal:  Infection       Date:  2018-12       Impact factor: 3.553

3.  In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-beta-lactamase-inhibitor combinations.

Authors:  R B Clark; P D Lister; L Arneson-Rotert; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 4.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.

Authors:  S Bajaksouzian; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

6.  Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.

Authors:  M A Visalli; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 7.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 8.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

9.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

10.  Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.

Authors:  R Shawar; M LaRocco; T G Cleary
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.